Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004120293 | SCV003587187 | uncertain significance | not specified | 2021-11-05 | criteria provided, single submitter | clinical testing | The c.2062A>G (p.S688G) alteration is located in exon 11 (coding exon 11) of the PDZD2 gene. This alteration results from a A to G substitution at nucleotide position 2062, causing the serine (S) at amino acid position 688 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003434615 | SCV004150082 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | PDZD2: BS2 |